Tuesday, September 15, 2009

Natus Medical Inc. Is Pulling Back After The Bell - Trading Markets (press release)


Natus Medical Inc. Is Pulling Back After The Bell
Trading Markets (press release)
(rttnews) - Natus Medical Inc. (BABY | Quote | Chart | News | powerrating) gapped up Tuesday and climbed in early trade. The stock settled into a range for ...

and more »

AFTER THE BELL-Rogers rises, Adobe falls - Forbes


AFTER THE BELL-Rogers rises, Adobe falls
Forbes
NEW YORK, Sept 15 (Reuters) - Shares of Rogers Corp rose 6.3 percent after the closing bell on Tuesday after it said it raised its third-quarter outlook, ...


Adobe to buy Omniture for $1.8B, 3Q profit slides - The Associated Press


Adobe to buy Omniture for $1.8B, 3Q profit slides
The Associated Press
Adobe's shares took a hit in after-hours trading, falling $1.50, or 4.2 percent, to $34.12. The stock had closed at $35.62 in regular trading earlier ...

and more »

Adobe to acquire Omniture; CEO calls move a 'game-changer' - ZDNet


Adobe to acquire Omniture; CEO calls move a 'game-changer'
ZDNet
Shares of Adobe were up slightly in regular trading, closing at $35.62. but were slipping in after-hours trading, down more than 4 percent. ...

and more »

Financials, energy lead market rise - Vancouver Sun


Financials, energy lead market rise
Vancouver Sun
The S&P/TSX composite index climbed 78.81 points, or 0.70%, to 11332.04, after falling as low as 11167.35 in after-hours trading this weekend. ...

and more »

Yahoo! (YHOO) Shares Spike as Bernstein Upgrades to Outperform - StreetInsider.com (subscription)


Yahoo! (YHOO) Shares Spike as Bernstein Upgrades to Outperform
StreetInsider.com (subscription)
(Nasdaq: YHOO) have jumped in today's after-hours trading session as Bernstein has issued a late-day upgrade. After closing at $15.56, the stock most ...

and more »

CEL-SCI Gains Reach Questionable Levels (CVM)

CEL-SCI Corp. (AMEX: CVM) has gone absolutely bonkers today on exponential trading volume because of its fairly small market cap, a huge share float, a low share price… and swine flu or H1N1 news….. We have the details on the full news over at BioHealthInvestor.com, but it gets really hard to not throw up a red flag here with a caveat emptor or surgeon general warning for traders.  As of 1:32 PM EST we have now seen 48 million shares trade hands and this one is up 77% at $1.63.  It also hit a new 52-week high today of $1.82, yet its 52-week low is all the way down at $0.14. This company has been around forever back before 1995, and it has never regained its share prices from way back in the day….  Whether this one can rise further or not, you might as well put it on your new active trader alert for small cap and low-priced stocks.  Once you see volume of that magnitude, it is usually quite some time before you see ‘average volume’ again….    -JON OGG


Wells Fargo fires worker for alleged misconduct - MarketWatch


Wells Fargo fires worker for alleged misconduct
MarketWatch
Wells Fargo's shares were at $27.87, down 0.2%, in after-hours trading. The stock has fallen about 20% in the past year.

and more »

Martha Stewart Volume Already Passes Full Day in 30 minutes (MSO)

Martha Stewart Living Omnimedia Inc. (NYSE: MSO) is soaring on news of the new exclusive pact with the The Home Depot Inc. (NYSE: HD).  Full details are here from last night’s release, but what is so helpful is that this ‘exclusive’ pact is another pact that does not appear to be a replacement pact and the company noted that it still has Macy’s and other top retail outlets to create, sell, and distribute the Martha wares….. MSO shares are up 8% at $7.40, which is a tad lower than teh $7.50 high in pre-market trading that we saw.  Also worth noting is that the trading volume is now over 320,000 shares and the average volume is only 280,000 shares or so.  So in less than 30 minutes, this one is effectively heading into ‘exponential volume territory.’ -JON OGG 99:57 AM EST)


BEFORE THE BELL -2: US HOT STOCKS TO WATCH - Zawya


BEFORE THE BELL -2: US HOT STOCKS TO WATCH
Zawya
Shares fell 5% to $4.16 in after-hours trading. Esterline Corp. (ESL), a maker of materials and sensors for the aerospace and defense industries, ...

and more »

Citi Getting a New Uncle? (C)

Citigroup Inc. (NYSE: C) may be in for a huge day.  Last night brought reports that Uncle Same, the U.S. government, might be selling part of its massive stake.  Reports from multiple sources gave October as the month that the sale could begin.  Be advised that this is not a total exit of the government, but it is a start and would lead to the independent recovery of Citi.  This could also take months and months to be completed as this is roughly a 34% stake. Expect this to be today’s most active stock.  At 8:54 AM EST we have seen 23 million shares trade hands and the stock is down 1% at $4.48.-JON OGG


Pipeline Setback for Sanofi and Regeneron - Seeking Alpha


Pipeline Setback for Sanofi and Regeneron
Seeking Alpha
The candidate is in phase III studies for each of these indications. Regeneron's shares fell 6.9% in after-hours trading.

and more »

Asian Stocks Recover Losses a Year After Lehman's Bankruptcy - Bloomberg


Asian Stocks Recover Losses a Year After Lehman's Bankruptcy
Bloomberg
Crude oil in New York was little changed in after-hours trading at $68.81 a barrel. Oil closed below $100 for the first time since its July 11, ...


Sugar Mills in India 'Miss Import Bus' as Prices Peak - Bloomberg


Sugar Mills in India 'Miss Import Bus' as Prices Peak
Bloomberg
Raw-sugar futures for March delivery rose as much as 0.7 percent to 23.85 cents a pound in after-hours trading in New York. The rally in 2009 has topped ...

and more »

Asian Stocks Recover Losses a Year After Lehman Failure Sparked ... - Bloomberg


Asian Stocks Recover Losses a Year After Lehman Failure Sparked ...
Bloomberg
Crude oil in New York was little changed in after-hours trading at $68.81 a barrel. Oil closed below $100 for the first time since its July 11, ...


US looking at selling Citi shares - Financial Express


US looking at selling Citi shares
Financial Express
... sold at once in a managed offering, Bloomberg reported. Citi's shares traded at $4.39 on Monday in after hours trading, down 2.9 per cent from their close.

and more »

Monday, September 14, 2009

Asian Stocks Fluctuate as Telstra, Aiful Slump; Rio Advances - Bloomberg


Asian Stocks Fluctuate as Telstra, Aiful Slump; Rio Advances
Bloomberg
Crude oil in New York was little changed in after-hours trading at $68.87 a barrel. Oil closed below $100 for the first time since its July 11, ...

and more »

Synovus To Raise $350M in Stock Offer - TheStreet.com


Synovus To Raise $350M in Stock Offer
TheStreet.com
In after-hours trading, the stock retreated, however, giving up 20 cents, or 5.3%, to $3.60, as traders likely priced in dilution. Follow TheStreet.com on ...

and more »

Analyst upgrades Yahoo, citing low valuation - MarketWatch


Analyst upgrades Yahoo, citing low valuation
MarketWatch
After closing the regular session Monday slightly lower at $15.57, Yahoo shares rose 1.8% to $15.85 in after-hours trading. "Although many were disappointed ...

and more »

Pall Q4 Earnings Top Estimate - RTT News


RTT News

Pall Q4 Earnings Top Estimate
RTT News
... closed Monday's regular trading session at $32.60, up 26 cents and gained an additional 65 cents or 1.99% in after hours trading. by RTT Staff Writer.

and more »

Lubrizol lifts 2009 profit outlook - Forbes


Lubrizol lifts 2009 profit outlook
Forbes
In after-hours trading, shares of Lubrizol added $1.27 to $68.14. Shares fell 67 cents to close at $66.87 in the regular session.

and more »

AFTER THE BELL-Solutia shares rise on guidance - Interactive Investor


AFTER THE BELL-Solutia shares rise on guidance
Interactive Investor
Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial Services Authority. ...

and more »

Genesis Lease Says It Is In Talks With Another Party On Possible ... - RTT News


Genesis Lease Says It Is In Talks With Another Party On Possible ...
RTT News
Genesis shares closed Monday's regular trading session at $7.80, up 84 cents or 12.07% and gained an additional 20 cents or 2.56% in after hours trading. by ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Dendreon Stock and Options Go Exponential (DNDN)

Dendreon Corp. (NASDAQ: DNDN) is surging on exponential volume today as traders are speculating, and hoping, that the company will become a takeover target.  The word today is over hopes of a “European drug/bio/ buyer”.  At 2:05 PM EST we have shares up almost 12% at $26.69 and volume is exponential at 8.8 million shares vs. average volume of 2.8 million shares.  The real interest though is in the CALL options, particularly when you look at the SEPT-2009 CALL activity below.  These expire this coming Friday.

Strike Volume  Op.Int.
$24.00    3,289    4,477
$25.00    15,477    15,844
$26.00    7,338    4,251
$27.00    1,854    2,814
$28.00    1,955    5,963
$29.00    677    2,338
$30.00    4,537    7,709
Here is the OCT-2009 Options activity:
Strike Volume  Op.Int.
$24.00    1,269    2,610
$25.00    1,056    2,156

JON C. OGG


AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Expect More Upside From This Oil Refinery Firm - CNBC


Expect More Upside From This Oil Refinery Firm
CNBC
Frontier Oil ended last week at $13.40 after rising slightly Friday and inched up another nickel in after-hours trading. For the calls purchased Friday to ...

and more »

About this author: - Seeking Alpha


About this author:
Seeking Alpha
... reported a loss of $12MM or $0.16/shr on Friday missing Wall St.'s expectations and sending the stock down to $43.80 or 4.1% in after hours trading. ...

and more »

Obama, Goodyear, Cooper, and China (GT, CTB)

The Obama Adminstration has levied huge import tariffs on imported Chinese tires claiming that they are exported to the US in a manner which damages the American tire industry unfairly.  As we asked in the UNUSUAL SUSPECTS this weekend, “Did President Obama just say, “Blue Horseshoe loves Goodyear?”…. Goodyear Tire & Rubber Co. (NYSE: GT) is up over 6% after the open and at 9:34 AM EST we have seen 495,000 shares trade hands.  Elsewhere we see that Cooper Tire & Rubber Co. (NYSE: CTB) is up over 8% at $15.80 at the same time, but that is on under 200,000 shares of stock.  -JON OGG


Credit Market Overview: Sept 14, 2009 - istockAnalyst.com (press release)


Credit Market Overview: Sept 14, 2009
istockAnalyst.com (press release)
... reported a loss of $12MM or $0.16/shr on Friday missing Wall St.'s expectations and sending the stock down to $43.80 or 4.1% in after hours trading. ...


AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


BEFORE THE BELL: US Stk Futures Fall Amid Trade War Worries - Wall Street Journal


BEFORE THE BELL: US Stk Futures Fall Amid Trade War Worries
Wall Street Journal
Shares of Regeneron fell 8.6% to $20.01 in after-hours trading. Sanofi-Aventis' American depositary shares closed Friday at $35.05, up 0.4%, ...

and more »

Ariad Study Continues Ramping Shares (ARIA)

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is one of the top gainers this morning after announcing the result of first interim analysis of Phase 3 ‘Succeed Trial’ of Oral Ridaforolimus in metastatic sarcoma… the independent Data Monitoring Committee of the Phase 3 SUCCEED trial has completed the first interim efficacy analysis and has recommended that it continues to full patient enrollment and completion.  The safety data. At 8:50 AM EST shares are up close to 16% at $3.03 on over 800,000 shares.  Average volume is 2.9 million shares.  -JON OGG


AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Call Buyers See Frontier Oil Going Higher - TheStreet.com


Call Buyers See Frontier Oil Going Higher
TheStreet.com
Frontier Oil ended last week at $13.40 after rising slightly Friday and inched up another nickel in after-hours trading. For the calls purchased Friday to ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Patience Pays Off For Theravance - Stock To Watch - RTT News


Patience Pays Off For Theravance - Stock To Watch
RTT News
THRX, which has traded in the range of $4.32 - $18.56, closed Friday's trade at $18.20. In after-hours trading the stock was up 4.4% at $19. by RTT Staff ...

and more »

Sunday, September 13, 2009

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch


Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...

and more »

Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch


Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...


AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch


Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...

and more »

Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch


Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch


Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...

and more »

Jim Cramer mention boosts Ceragon shares - Globes


Jim Cramer mention boosts Ceragon shares
Globes
In after-hours trading on Nasdaq the share jumped 12.5%. On the TASE the share was up 9.42% to NIS 29.50 by early afternoon trading today. ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...